Top Story

Morning Read: VC sees opportunities in areas where Pharma is pulling back

Current medical news from today includes opportunities in areas that Pharma is abandoning, the limits of genomics and the waning cancer drug shortage.

Counter-intuitive as it may be, investing in areas that pharma is abandoning could yield great returns for investors. Just look at anti-bacterials in the ’90s and 2000s, says VC Bruce Booth in a Forbes column. So where should investors be looking today? Neuroscience, heart failure and obesity.

The shortage of cancer drugs that’s plagued hospitals for almost two years now has eased, although not completely, according to cancer doctors.

A recent study by Johns Hopkins researchers brings a reality check to the potential (and the limits) of genome sequencing in predicting disease.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

Johnson & Johnson and Bristol-Myers Squibb both reported good news on their cancer drugs over the weekend. JNJ’s Zytiga slowed prostate cancer growth in a study of patients who hadn’t undergone chemotherapy, which will help the pharma in seeking approval for expanded use of the drug. And BMY has promising data for an experimental immunotherapy drug that could fight three types of cancer.

This new app developed by researchers at the University of Missouri encourages people to stick out their tongues during photos. It uses the Chinese concept of zheng to determine illness by analyzing color and coatings on the tongue.